Galectin Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Galectin Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Galectin Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Galectin Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $13k | 7.6k | 1.66 |
| 2023-09-30 | $15k | 8.0k | 1.92 |
| 2023-06-30 | $7.8k | 5.4k | 1.44 |
| 2022-12-31 | $7.2k | 6.4k | 1.13 |
| 2022-09-30 | $0 | 8.5k | 0.00 |
| 2022-06-30 | $11k | 8.5k | 1.34 |
| 2022-03-31 | $0 | 8.5k | 0.00 |
| 2021-12-31 | $31k | 8.5k | 3.66 |
| 2021-09-30 | $32k | 8.5k | 3.75 |
| 2021-06-30 | $48k | 12k | 4.00 |
| 2021-03-31 | $45k | 20k | 2.20 |
| 2020-12-31 | $216k | 97k | 2.23 |
| 2020-09-30 | $153k | 57k | 2.68 |
| 2020-06-30 | $208k | 68k | 3.06 |
| 2020-03-31 | $90k | 46k | 1.97 |
| 2019-12-31 | $89k | 32k | 2.84 |
| 2019-09-30 | $106k | 29k | 3.69 |
| 2019-06-30 | $27k | 6.7k | 4.00 |
| 2019-03-31 | $39k | 6.5k | 6.00 |
| 2018-12-31 | $29k | 8.6k | 3.41 |
| 2018-09-30 | $353k | 59k | 6.03 |
| 2018-06-30 | $257k | 40k | 6.40 |
| 2018-03-31 | $51k | 11k | 4.78 |
| 2017-12-31 | $37k | 11k | 3.35 |
| 2017-06-30 | $30k | 12k | 2.51 |
| 2017-03-31 | $27k | 12k | 2.25 |
| 2016-12-31 | $0 | 4.7k | 0.00 |
| 2016-09-30 | $0 | 4.7k | 0.00 |
| 2016-06-30 | $9.3k | 3.7k | 2.50 |
| 2016-03-31 | $9.3k | 3.7k | 2.50 |
| 2015-12-31 | $9.3k | 3.7k | 2.50 |
| 2015-09-30 | $10k | 4.6k | 2.22 |
| 2015-03-31 | $16k | 4.8k | 3.33 |
| 2014-12-31 | $16k | 4.5k | 3.59 |
| 2014-06-30 | $83k | 5.9k | 14.04 |
| 2014-03-31 | $133k | 8.6k | 15.35 |
| 2013-12-31 | $17k | 2.1k | 8.02 |
| 2013-09-30 | $21k | 2.1k | 9.91 |